Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
2.49M
-
Shares change
-
+512K
-
Total reported value, excl. options
-
$52.1M
-
Value change
-
+$10.8M
-
Number of buys
-
7
-
Number of sells
-
-2
-
Price
-
$20.90
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2018
12 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q2 2018.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.49M shares
.
Largest 10 shareholders include Parametric Portfolio Associates LLC (1.73M shares), GLENMEDE TRUST CO NA (369K shares), Pacer Advisors, Inc. (100K shares), NorthCoast Asset Management LLC (98.8K shares), FNY Investment Advisers, LLC (89.6K shares), World Asset Management Inc (47.4K shares), Pinnacle Wealth Planning Services, Inc. (29.2K shares), Kepos Capital LP (20K shares), Hexavest Inc. (1.13K shares), and Private Capital Group, LLC (567 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.